Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial

Original Article by Deena Beasley and Manas Mishra | Reuters | 17 April 2025

Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.

Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here